Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Protein Biomarkers in Alzheimer’s Disease
Caroline M Watson(Emory University), Nicholas T. Seyfried(Emory Healthcare)
Cited by 71
Related Papers
Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level
|Nature Neuroscience|2022|598
Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors
|Neuron|2021|176
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
|Nature Medicine|2023|172
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia
|Nature Medicine|2018|156
Multiplex SILAC Analysis of a Cellular TDP-43 Proteinopathy Model Reveals Protein Inclusions Associated with SUMOylation and Diverse Polyubiquitin Chains
|Molecular & Cellular Proteomics|2010|122